AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Recommendation of “Buy” by Analysts
Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have earned an average recommendation of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have covered the stock in the last year […]
More Stories
244 Arrested in 9-Day Prostitution Sting Operation in Florida
By Jack Phillips Officials in a Florida county announced last week that 244 suspects were arrested during a multi-day operation...
New Vehicle Inventory in April Declines, Affordability Worsens: Cox Automotive Analysis
By Naveen Athrappully Inventory of new vehicles decreased in April by 7.4 percent month over month and was down by...
With Middle East Tour, Trump Reshapes US Foreign Policy
By Emel Akan WASHINGTON—President Donald Trump’s recent tour of the Middle East sent a clear message that economic interests and...
Deal Reached to End New Jersey Transit Strike: Union Chairman
By Joseph Lord Three days after the start of a strike by New Jersey transit employees, an agreement has been...
D. E. Shaw & Co. Inc. Has $3.50 Million Stake in CSX Co. (NASDAQ:CSX)
D. E. Shaw & Co. Inc. trimmed its stake in CSX Co. (NASDAQ:CSX – Free Report) by 91.6% during the...
Focus Partners Wealth Sells 327,820 Shares of WEX Inc. (NYSE:WEX)
Focus Partners Wealth reduced its stake in WEX Inc. (NYSE:WEX – Free Report) by 98.5% during the fourth quarter, HoldingsChannel.com...